Unitika (Japan)

Recent papers from Unitika (Japan)

1. Determinants of Serum PFOA Concentrations Among Residents in the Industrially Contaminated Area 11 Years After PFOA Production Cessation in Osaka, JapanJournal of Xenobiotics · 2026
2. Complementary and alternative medicine and the risk of delayed diagnosis and treatment for cancer patients: a systematic review and meta-analysisNowotwory Journal of Oncology · 2026
3. Deep learning-based survival monitoring for antimicrobial efficacy evaluation in the silkworm infection modelScientific Reports · 2026
4. Age- and program-related heterogeneity in rubella IgG antibody titers among adults undergoing municipal antibody testing in JapanVaccine X · 2026
5. Association Between Efficacy and Pharmacokinetics of DMB-3115 and its Originator Ustekinumab in Patients with Chronic Plaque Psoriasis: An Exposure–Response AnalysisAdvances in Therapy · 2026
6. Pharmacokinetics, Safety, and Immunogenicity of DMB-3115, a Ustekinumab Biosimilar for Immune-Mediated Diseases, in Healthy Japanese Male Participants: A Randomized, Double-Blind, Single-Dose StudyAdvances in Therapy · 2026
7. Prioritizing Sustainable Digital Transformation Strategies for a Smart, Green, and Participatory Bahçelievler Municipality2026
8. Development of an interprofessional education program for aspiration pneumonia care: an action research studyEuropean Geriatric Medicine · 2026
9. The effect of hook appendage length on species' catch probability in a Pacific halibut longline fisheryAquaculture and Fisheries · 2026
10. Interim analysis of effectiveness of JN.1-adapted conventional and self-amplifying mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infection in adults aged ≥60 years, Japan, October 2024–April 2025Vaccine · 2026
11. Phase‐Separated Structures and Fracture Toughness of Epoxy/Imide‐Terminated Reactive Oligomer With Flexible ChainPolymer Engineering and Science · 2026
12. Time-Structured Detection of Pre-Event Cardiovascular Instability Using CPAP-Derived Cheyne–Stokes BreathingEuropean Heart Journal - Digital Health · 2026
13. Prediction of Human Serum Concentration–Time Profiles of Golimumab and Ustekinumab Using Pharmacokinetic Data From Common Marmosets With Assessment of Anti‐Drug AntibodiesBiopharmaceutics & Drug Disposition · 2026
14. THE UPSTREAM FAILURE: AI Ethics, Human Behaviour, and the Case for Upstream Governance™2026
15. Evaluation of drug-drug interaction between nacubactam and β-lactam antibiotic (cefepime, aztreonam, meropenem, or piperacillin) in Japanese healthy participantsAntimicrobial Agents and Chemotherapy · 2026
16. In vitro activity of the novel β-lactamase inhibitor nacubactam against a nationwide collection of carbapenem-resistant Enterobacterales in JapanJAC-Antimicrobial Resistance · 2026
17. Nationwide Detection and Molecular Characterization of Hepatitis E Virus RNA in Retail Pork Meat in JapanViruses · 2026
18. Pharmacokinetic analysis of nacubactam, a novel β-lactamase inhibitor, co-administered with meropenem in patients with a complicated urinary tract infectionJAC-Antimicrobial Resistance · 2026
19. Bo‘lajak O‘QITUVCHILARDA Raqamli Va Axborot Xavfsizligi Madaniyatini Sun’iy Intellekt Vositasida ShakllantirishSCIENCE TIME · 2026
20. Prevalence and Associated Factors of Depressive Symptoms in Bereaved Family Members of Terminally Ill Cancer Patients Receiving Home CarePalliative Medicine Reports · 2026